DUBLIN–(BUSINESS WIRE)–The “Hong Kong: CBD and Cannabis Regulation 2022” report has been added to ResearchAndMarkets.com’s offering.
This report provides a detailed overview of the regulatory framework in place in Hong Kong for hemp, cannabis and CBD.
All cannabis plants are considered equal in Hong Kong law, which means that even low-THC hemp varieties are subject to the same restrictions as high-THC cannabis.
The regulatory environment for hemp appears to be more stringent than it once was in Hong Kong. In June 2022, law enforcement authorities proposed banning the manufacture, import, export, supply, sale, possession and delivery of CBD and any products containing CBD before the end of 2022.
Key Topics Covered:
1 Executive summary
2 Outlook
3 Hemp plant
4 Extracts as finished product
5 Finished products containing CBD and extracts
6 Import and export requirements
7 Medical cannabis
8 Recreational cannabis
9 Relevant laws
10 Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/uv8q39
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900